Medical Adhesive‐Related Skin Injuries in Oncology and Haematology Patients With Peripherally Inserted Central Catheters: A Prospective Descriptive Study

ABSTRACT Aim To determine the prevalence of MARSI associated with peripherally inserted central venous catheters (PICCs) in oncology and haematology patients, analyse the type of injury and identify risk factors. Methodology A prospective descriptive study was conducted from 9 June 2021 to 8 February 2022. The study population was oncology and haematology patients with a PICC. The variables to be studied included the presence of MARSI in relation to PICC maintenance, injury type, time to onset, mean healing time, and type of treatment received. A descriptive analysis of the entire sample was performed. Chi‐square and Student's t ‐test or Mann–Whitney U ‐tests were used to identify risk factors, depending on the nature of the variables. Results The sample studied was 342 PICCs inserted in 309 patients, 49% ( n = 169) women, and the mean overall age was 62.12 years (SD: 12.33). Seventy‐six per cent were oncology and 24% haematology patients. The prevalence of MARSI was 32% ( n = 111). The most common type of injury was erythema in 39% ( n = 42). The mean duration of the lesion was 20.90 days (SD: 31.44). Alkylating agents, among others, were identified as a risk factor. Conclusions The results indicate a high prevalence of MARSI. In agreement with the literature, mechanical injuries are the most frequent, and some antineoplastic treatments are a risk factor. This study may help to identify areas for improvement and design strategies for the prevention and treatment of MARSI. Relevance to Clinical Practice This study has implications for clinical practice, as it helps to identify areas for improvement and the most relevant clinical practice guideline recommendations to avoid this adverse event. Patient or Public Contribution No patient or public contribution.